Agilus Diagnostics, India-based diagnostic laboratory chain, has announced its collaboration with SEAS International LLC to establish a state-of-the-art referral laboratory in Oman. This strategic partnership aims to enable high-quality diagnostic testing services for the 5 million-strong population of Oman.

The agreement signing ceremony, graced by Issa Saleh Abdullah Alshibani, the Ambassador of Oman in India, witnessed the participation of key dignitaries including Dr Ibrahim Aghaithi, Chairman of SEAS International LLC, Ashish Bhatia, Chief Operating Officer of Agilus Diagnostics, and Mangesh Shirodkar, Chief Financial Officer of Agilus Diagnostics.

Anand. K, Managing Director & CEO, Agilus Diagnostics said, "Oman's burgeoning healthcare infrastructure and increasing privatisation within the sector are poised to drive the demand for diagnostic testing services in the country. Our partnership with SEAS International further enhances Agilus’ international presence across the Middle East, Sub-Saharan Africa, Commonwealth of Independent States and the SAARC region." 

Dr Ibrahim Aghaithi, Chairman, SEAS International, highlights the anticipated growth of the in-vitro diagnostics market in Oman. He forecasts a revenue of $99.07 million by 2024, with a projected compound annual growth rate (CAGR) of 2.32% from 2024 to 2028, leading to a market volume of $108.60 million by 2028.